Subscription Center
The surprise success this summer of a clinical trial on an antiretroviral-based vaginal microbicide provides new traction for efforts to combat AIDS in the developing world. Here are some new directions to expect for treatment and prevention of this widespread killer
August 25, 2010 |
Features
New ARV-based HIV-prevention strategies utilize progress in treatment
Features
Drug policy has focused on a policing approach of prohibition and incarceration, which has contributed to spreading HIV within the injection-drug community. Comprehensive drug reform policies are showing better results
A paucity of research on men who have sex with other men has done a disservice to efforts to prevent the spread of HIV
New research uncovers three methods of HIV development in the male genital tract that can make the virus look different from blood-borne populations
The first microbiome study of the penis offers some clues as to why removing foreskin cuts the risk of HIV infection in circumcised men
After years of false starts, a new generation of DNA vaccines and medicines for HIV, influenza and other stubborn illnesses is now in clinical trials
NIH researchers may have found antibodies that can neutralize most varieties of HIV, blocking it before it infects healthy cells. But stimulating their sparse natural production remains a hurdle in developing an antiviral therapy
The rise of HIV followed the cessation of widespread smallpox vaccination. A small study hints at a possible connection. Steve Mirsky reports
The new advice could make three to five million more people eligible to take antiretroviral drugs
New weapons take aim at "latent reservoirs" by rousing the invader from its hiding spot in immune cells
Are "elite controllers" the key to understanding HIV infection—and do their immune systems offer a new approach to developing an AIDS vaccine?
See what we're tweeting about
mdichristina MT @Bill_Gross: More than HALF of the world's population lives inside this circle: http://t.co/sko1883e1K mdichristina MT @jeffjarvis: very good BizWeek story on Google [x]. http://t.co/gnUEXSIzq7
DNLee5 #dispatchesDNLee: feeling better, appetite returned.but now I can't shake this sour stomach & heart burn. I blame the Cipro
Deadline: Aug 31 2013
Reward: $100,000 USD
The Geoffrey Beene Foundation Alzheimer’s Initiative (GBFAI) is launching the 2013 Geoffrey Beene Global NeuroDiscovery Challenge whose
Deadline: Jun 29 2013
Reward: $7,000 USD
The Seeker for this Challenge desires proposals for chemical methods that could rapidly degrade a dilute aqueous solution
Powered By: 
YES! Send me a free issue of Scientific American with no obligation to continue the subscription. If I like it, I will be billed for the one-year subscription.
